46
Catherine Crofts et al., «Hyperinsulinemia: A Unifying Theory of Chronic Disease?» Diabesity I, no. 4 (2015): 34—43.
47
W. Q. Qui et al., «Insulin-Degrading Enzyme Regulates Extracellular Levels of Amyloid Beta-Protein by Degradation» Journal of Biological Chemistry 273, no. 49 (1998): 32730—38.
48
Y. M. Li and D. W. Dickson, «Enhanced Binding of Advanced Glycation Endproducts (AGE) by the ApoE4 Isoform Links The Mechanism of Plaque Deposition in Alzheimer’s Disease» Neuroscience Letters 226, no. 3 (1997): 155—58.
49
Auriel Willette et al., «Insulin Resistance Predicts Brain Amyloid Deposition in Late Middle Aged Adults» Alzheimer’s & Dementia 11, no. 5 (2015): 504—10.
50
H. Bruehl et al., «Cognitive Impairment in Nondiabetic Middle-Aged and Older Adults Is Associated with Insulin Resistance» Journal of Clinical and Experimental Neuropsychology 32. no. 5 (2010): 487—93.
51
Kaarin Anstey et al., «Association of Cognitive Function with Glucose Tolerance and TV ceclor ics of Glucose Tolerance over 12 Years in the AusDiab Study» Alzheimer’s Research & Therapy 7, no. 1 (2015): 48; S. E. Young, A. G. Mainous 3rd, and M. Carnemolla, «Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort» Diabetes Care 29, no. 12 (2006): 2688—93.
52
Dimitrios Kapogiannis et al» «Dysfunctionally Phosphorylated Type 1 Insulin Receptor Substrate in Neural-Derived Blood Exosomes of Preclinical Alzheimer’s Disease» FASEB Journal 29, no. 2 (2015): 589—96.
53
R. H. Freire et al., «Wheat Gluten Intake Increases Weight Gain and Adiposity Associated with Reduced Thermogenesis and Energy Expenditure in an Animal Model of Obesity» International Journal of Obesity 40, no. 3 (2016): 479—87; Fabiola Lacerda Pires Soares et al., «Gluten-Free Diet Reduces Adiposity, Inflammation and Insulin Resistance Associated with the Induction of PPAR Alpha and PPAR-Gamma Expression» Journal of Nutritional Biochemistry 24, no. 6 (2013): 1105—11.
54
Sylvie Normand et al., «Influence of Dietary Fat on Postprandial Glucose Metabolism (Exogenous and Endogenous) Using Intrinsically С-Enriched Durum Wheat» British Journal of Nutrition 86, no. 1 (2001): 3—11.
55
Robin C. Hilsabeck et al., «Cognitive Efficiency Is Associated with Endogenous Cytokine Levels in Patients with Chronic Hepatitis C,» Journal of Neuroimmunology 221, no. 1—2 (April 2010): 53—61, DOI: 10.1016/j. jneuroim.2010.01.017; Tessa N. van den Kommer et al., «The Role of Lipoproteins and Inflammation in Cognitive Decline: Do They Interact?,» Neurobiology of Aging 33, no. 1 (January 2012): 196.e1—196.e12, DOI: 10.1016/j. neurobiolaging.2010.05.024.; Shino Magaki et al., «Increased Production of 5 Inflammatory Cytokines in Mild Cognitive Impairment,» Experimental Gerontology 42, no. 3 (March 2007): 233—240, DOI: 10.1016/j. exger.2006.09.015.; M. G. Dik et al., «Serum Inflammatory Proteins and Cognitive Decline in Older Persons,» Neurology 64, no. 8 (April 26, 2005): 1371—1377, DOI: 10.1212/01.WNL.0000158281.08946.68.
56
Ryan N. Dilger and Rodney W. Johnson, «Aging, Microglial Cell Priming, and the Discordant Central Inflammatory Response to Signals from the Peripheral Immune System,» Journal of Leukocyte Biology 84, no. 4 (October 2008): 932—939, DOI: 10.1189/jlb.0208108; H. A. Rosczyk, N. L. Sparkman, and R. W. Johnson, «Neuroinflammation and Cognitive Function in Aged Mice Following Minor Surgery,» Experimental Gerontology 43, no. 9 (September 2008): 840—846, DOI: 10.1016/j. exger.2008.06.004; Godbout et al., «Exaggerated Neuroinflammation and Sickness Behavior in Aged Mice Following Activation of the Peripheral Innate Immune System,» 1329—1331; Aine Kelly et al., «Activation of p38 Plays a Pivotal Role in the Inhibitory Effect of Lipopolysaccharide and Interleukin-1 Beta on Long-Term Potentiation in Rat Dentate Gyrus,» Journal of Biological Chemistry 278, no. 21 (May 23, 2003): 19453—19462, DOI: 10.1074/jbc. M301938200.
57
Arthur A. Simen et al., «Cognitive Dysfunction with Aging and the Role of Inflammation,»» Therapeutic Advances in Chronic Disease 2, no. 3 (May 2011): 175—95, DOI: 10.1177/2040622311399145.
58
Pritam Das, «Overview – Alzheimer’s Disease and Inflammation Lab: Pritam Das – Mayo Clinic Research,» Mayo Clinic, accessed October 20, 2016, http:// www.mayo.edu/research/labs/alzheimers-disease-infl ammation/overview.
59
Arthur A. Simen et al., «Cognitive Dysfunction with Aging and the Role of Inflammation,»» Therapeutic Advances in Chronic Disease 2, no. 3 (May 2011): 175—95, DOI: 10.1177/2040622311399145.
60
Arthur A. Simen et al., «Cognitive Dysfunction with Aging and the Role of Inflammation,»» Therapeutic Advances in Chronic Disease 2, no. 3 (May 2011): 175—95, DOI: 10.1177/2040622311399145.
61
Roberto Berni Canani et al., «Potential Benefiсial Effects of Butyrate in Intestinal and Extraintestinal Diseases,» World Journal of Gastroenterology 17, no. 12 (March 28, 2011): 1519—1528, DOI: 10.3748/wjg. v17.i12.1519.
62
Antoine Louveau et al., «Structural and Functional Features of Central Nervous System Lymphatic Vessels,» Nature 523, no. 7560 (July 16, 2015): 337—341, DOI: 10.1038/nature14432.
63
Matam Vijay-Kumar et al., «Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5,» Science 328, no. 5975 (April 9, 2010): 228—231, DOI: 10.1126/science.1179721.
64
Jean-Pascal De Bandt, Anne-Judith Waligora-Dupriet, and Marie-Josе Butel, «Intestinal Microbiota in Inflammation and Insulin Resistance: Relevance to Humans,» Current Opinion in Clinical Nutrition and Metabolic Care 14, no. 4 (July 2011): 334—340, DOI: 10.1097/MCO.0b013e328347924a.
65
Anthony J. Harmar et al., «Pharmacology and Functions of Receptors for Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide: IUPHAR Review 1,» British Journal of Pharmacology 166, no.1 (May 2012): 4—17, DOI: 10.1111/j.1476—5381.2012.01871.x
66
Amali E. Samarasinghe, Scott A. Hoselton, and Jane M. Schuh, «SpatioTemporal Localization of Vasoactive Intestinal Peptide and Neutral Endopeptidase in Allergic Murine Lungs,» Regulatory Peptides 164, no. 2—3 (September 24, 2010): 151—157, DOI: 10.1016/j.regpep.2010.05.017.
67
Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal antiinflammatory drugs: nested case-control study. Lancet. 2005;365 (9458):475—81.
68
Sarah Myhill, Norman E. Booth, and John McLaren-Howard, «Targeting Mitochondrial Dysfunction in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) – a Clinical Audit,» International Journal of Clinical and Experimental Medicine 6, no. 1 (2013): 1—15.
69
hhttps://medicine-boy.ru/cikl_krebsa/
70
Мовсесян А. Г. Профилактика возрастзависимых заболеваний. – М.: Центрполиграф, 2018, 479 с.
